WCG
Weaver Consulting Group’s Edwards Lifesciences EW Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $3.63M | Sell |
46,379
-206
| -0.4% | -$16.1K | 1% | 28 |
|
2025
Q1 | $3.38M | Sell |
46,585
-350
| -0.7% | -$25.4K | 1.02% | 24 |
|
2024
Q4 | $3.47M | Sell |
46,935
-558
| -1% | -$41.3K | 1.07% | 23 |
|
2024
Q3 | $3.13M | Sell |
47,493
-359
| -0.8% | -$23.7K | 1% | 26 |
|
2024
Q2 | $4.42M | Buy |
47,852
+8,400
| +21% | +$776K | 1.54% | 15 |
|
2024
Q1 | $3.77M | Sell |
39,452
-1,000
| -2% | -$95.6K | 1.4% | 17 |
|
2023
Q4 | $3.08M | Sell |
40,452
-2,185
| -5% | -$167K | 1.25% | 20 |
|
2023
Q3 | $2.95M | Buy |
42,637
+1,524
| +4% | +$106K | 1.33% | 18 |
|
2023
Q2 | $3.88M | Sell |
41,113
-2
| -0% | -$189 | 1.71% | 13 |
|
2023
Q1 | $3.4M | Sell |
41,115
-1
| -0% | -$83 | 1.56% | 14 |
|
2022
Q4 | $3.07M | Buy |
41,116
+1,566
| +4% | +$117K | 1.57% | 13 |
|
2022
Q3 | $3.27M | Buy |
39,550
+76
| +0.2% | +$6.28K | 1.88% | 12 |
|
2022
Q2 | $3.75M | Buy |
39,474
+549
| +1% | +$52.2K | 2.1% | 10 |
|
2022
Q1 | $4.58M | Buy |
38,925
+200
| +0.5% | +$23.5K | 2.22% | 10 |
|
2021
Q4 | $5.02M | Buy |
38,725
+3
| +0% | +$389 | 2.42% | 10 |
|
2021
Q3 | $4.38M | Buy |
38,722
+118
| +0.3% | +$13.4K | 2.38% | 9 |
|
2021
Q2 | $4M | Buy |
38,604
+780
| +2% | +$80.8K | 2.25% | 9 |
|
2021
Q1 | $3.16M | Buy |
37,824
+1,494
| +4% | +$125K | 1.94% | 12 |
|
2020
Q4 | $3.31M | Buy |
36,330
+675
| +2% | +$61.6K | 2.07% | 11 |
|
2020
Q3 | $2.85M | Buy |
35,655
+1,575
| +5% | +$126K | 1.64% | 11 |
|
2020
Q2 | $2.36M | Sell |
34,080
-663
| -2% | -$45.8K | 1.37% | 16 |
|
2020
Q1 | $2.18M | Buy |
34,743
+639
| +2% | +$40.2K | 1.43% | 14 |
|
2019
Q4 | $2.5M | Buy |
34,104
+1,365
| +4% | +$100K | 1.34% | 17 |
|
2019
Q3 | $2.37M | Hold |
32,739
| – | – | 1.25% | 19 |
|
2019
Q2 | $2.02M | Sell |
32,739
-390
| -1% | -$24K | 1.1% | 19 |
|
2019
Q1 | $2.05M | Buy |
+33,129
| New | +$2.05M | 0.58% | 28 |
|